Delivery systems of current biologicals for the treatment of chronic cutaneous wounds and severe burns

Adv Drug Deliv Rev. 2018 Apr:129:219-241. doi: 10.1016/j.addr.2018.03.002. Epub 2018 Mar 19.

Abstract

While wound therapy remains a clinical challenge in current medical practice, much effort has focused on developing biological therapeutic approaches. This paper presents a comprehensive review of delivery systems for current biologicals for the treatment of chronic wounds and severe burns. The biologicals discussed here include proteins such as growth factors and gene modifying molecules, which may be delivered to wounds free, encapsulated, or released from living systems (cells, skin grafts or skin equivalents) or biomaterials. Advances in biomaterial science and technologies have enabled the synthesis of delivery systems such as scaffolds, hydrogels and nanoparticles, designed to not only allow spatially and temporally controlled release of biologicals, but to also emulate the natural extracellular matrix microenvironment. These technologies represent an attractive field for regenerative wound therapy, by offering more personalised and effective treatments.

Keywords: Biologic; Chronic wounds; Cytokine; Extracellular matrix; Growth factor; Hydrogel; Nanoparticle; Scaffold; Stem cells; Wound healing; mRNA.

Publication types

  • Review

MeSH terms

  • Animals
  • Burns / drug therapy*
  • Chronic Disease
  • Drug Delivery Systems*
  • Humans
  • Skin Diseases / drug therapy*
  • Wound Healing / drug effects*